Risk prediction for complex diseases: application to Parkinson disease

Area of Science:

• Neurogenetics
• Genetic Epidemiology
• Parkinson Disease Research

Background:

• Parkinson disease (PD) risk assessment traditionally relies on clinical and demographic factors.
• Integrating genetic information and family history can potentially enhance PD risk prediction accuracy.
• Genome-wide association studies (GWAS) have identified single-nucleotide polymorphisms (SNPs) associated with PD.

Purpose of the Study:

• To evaluate the predictive capability of clinical and demographic data for Parkinson disease risk.
• To assess the added value of genetic information (GWAS-derived SNPs) and family history in PD risk prediction.
• To compare the discriminatory capacity of models incorporating different combinations of risk factors.

Main Methods:

• Utilized data from 1,967 participants in the dbGAP NeuroGenetics Research Consortium.
• Calculated risk allele scores based on weighted counts of minor alleles for PD-associated SNPs.
• Constructed five predictive models and evaluated discriminatory capability using the area under the curve (AUC).

Main Results:

• Both family history and genetic risk scores significantly increased the risk for Parkinson disease.
• The model combining family history and genetic risk information yielded the highest AUC.
• No significant difference in AUC was observed between models using only family history versus only genetic information.

Conclusions:

• Incorporating GWAS-derived genotypes and/or family history improves discriminatory capacity for PD risk beyond demographic factors.
• Genotype data and family history showed similar, statistically significant contributions in the full model.
• Clinical utility for PD genetic risk prediction requires identifying additional genetic factors or improved prediction methodologies.